Legislation – a powerful tool for promoting massive changes
The combination of pertuzumab and trastuzumab had superior antitumor activity in women with early HER2-positive breast cancer, according to Phase II study results of the NeoSphere neoadjuvant trial.
Details of these study results were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12, 2010.
Legislation – a powerful tool for promoting massive changes
Tackling breast cancer screening in conservative communities
Post-diagnosis diet, nutrition and cancer prognosis
Laser oncosurgery - A new perspective in treating cancer
WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India
Alternative livelihood training programme for rural women who are employed in the tobacco industry in India
Navigating breast cancer treatment for young patients
Choosing Wisely for young women with breast cancer: BMC data
Choosing Wisely for young women with breast cancer: Radiotherapy